GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Brookline Capital Acquisition Corp (NAS:BCACW) » Definitions » Machinery, Furniture, Equipment

BCACW (Brookline Capital Acquisition) Machinery, Furniture, Equipment : $0.00 Mil (As of Mar. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Brookline Capital Acquisition Machinery, Furniture, Equipment?

Brookline Capital Acquisition's Machinery, Furniture, Equipment for the quarter that ended in Mar. 2022 was $0.00 Mil.

Brookline Capital Acquisition Machinery, Furniture, Equipment Historical Data

The historical data trend for Brookline Capital Acquisition's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brookline Capital Acquisition Machinery, Furniture, Equipment Chart

Brookline Capital Acquisition Annual Data
Trend Dec20 Dec21
Machinery, Furniture, Equipment
- -

Brookline Capital Acquisition Quarterly Data
Jun20 Sep20 Mar21 Jun21 Sep21 Dec21 Mar22
Machinery, Furniture, Equipment Get a 7-Day Free Trial - - - - -

Brookline Capital Acquisition Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Brookline Capital Acquisition Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Brookline Capital Acquisition Corp (NAS:BCACW) » Definitions » Machinery, Furniture, Equipment
Comparable Companies
MCAE LAAA SPK IGNY WRPT CPAQ LZGI FOXW ESSC DILA GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
280 Park Avenue, Suite 43W, New York, NY, USA, 10017
Website
https://www.brooklinecapitalacquisitioncorp.com
Brookline Capital Acquisition Corp is a blank check company.

Brookline Capital Acquisition Headlines

From GuruFocus

Apexigen Announces Nature Medicine Publication and ASCO Presentation on the Phase 2 PRINCE Trial Showcasing Distinct Biosignatures in Metastatic Pancreatic Cancer Patients Treated with Sotigalimab and/or Nivolumab in Combination with Chemotherapy

By GuruFocusNews GuruFocusNews • 06-06-2022

Apexigen Appoints William Duke as Chief Financial Officer

By GuruFocusNews GuruFocusNews • 06-18-2022

Moore Kuehn Encourages VCKA, RNER, BCAC, and SUMR Investors to Contact Law Firm

By PRNewswire PRNewswire • 03-24-2022

Apexigen Appoints William Duke as Chief Financial Officer

By GuruFocusNews GuruFocusNews • 06-28-2022

Apexigen Appoints William Duke as Chief Financial Officer

By GuruFocusNews GuruFocusNews • 06-08-2022

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates VOLT, BCAC, VEC, OAS

By PRNewswire PRNewswire • 03-21-2022

Apexigen and Brookline Capital Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Immuno-oncology Company

By GuruFocusNews GuruFocusNews • 03-18-2022

Brookline Capital Acquisition Corp. Announces the Separate Trading of its Common Stock and Warrants, Commencing February 22, 2021

By GlobeNewswire GlobeNewswire • 02-18-2021

Apexigen Announces Nature Medicine Publication and ASCO Presentation on the Phase 2 PRINCE Trial Showcasing Distinct Biosignatures in Metastatic Pancreatic Cancer Patients Treated with Sotigalimab and/or Nivolumab in Combination with Chemotherapy

By GuruFocusNews GuruFocusNews • 06-16-2022

Apexigen Announces Nature Medicine Publication and ASCO Presentation on the Phase 2 PRINCE Trial Showcasing Distinct Biosignatures in Metastatic Pancreatic Cancer Patients Treated with Sotigalimab and/or Nivolumab in Combination with Chemotherapy

By GuruFocusNews GuruFocusNews • 07-06-2022